Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Gastroenterology | Family Medicine

Rectal Cancer Clinical Trials


A listing of Rectal Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Delaware

Newark : Helen F. Graham Cancer Center-Christiana Care

Dose Finding Study of Twice Weekly IMMU-130 in Metastatic Colorectal Cancer

Florida

Tampa : H. Lee Moffitt Cancer Center and Research Institute

Pre-operative 5-Fluorouracil (5-FU) and Sorafenib With External Radiation in Locally Advanced Rectal Cancer

Georgia

Savannah : Memorial University Medical Center

NCCTG N1048: A Phase II/III Trial of Neoadjuvant FOLFOX, With Selective Use of Combined Modality Chemoradiation Versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection With Total Mesorectal Excision

View More »

Atlanta : Emory University Winship Cancer Institute

STA9090: Phase I Trial of Ganetespib, Capecitabine, and Radiation in Rectal Cancer

Indiana

Goshen : IUHealth Goshen Center for Cancer Care

Dose Finding Study of Twice Weekly IMMU-130 in Metastatic Colorectal Cancer

Massachusetts

Boston : Dana-Farber Cancer Institute

Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer

Boston : Massachusetts General Hospital

Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer

Weymouth : South Shore Hospital

Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer

New York

Bronx : Montefiore Medical Center - Weiler Campus

Exploratory Study Of The ERCC-1 Gene

Bronx : Montefiore Medical Center - Moses Campus

Exploratory Study Of The ERCC-1 Gene

Tennessee

Nashville : Vanderbilt Medical Center

Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer

Canada

Montreal : Centre Hospitalier Universitaire de Montréal

The Value of Botox-A for Management of Low Anterior Resection Syndrome

Israel

Tel Aviv : Sourasky Medical Center

Clinical Study-evaluate Performance&Safety "Aer-O-Scope" in Colon of Low Risk Patients

Netherlands

Amsterdam : NKI (Nederlands Kanker Instituut)

L-BLP25 (Stimuvax) in Rectal Cancer

Sweden

Göteborg : Sahlgrenska University Hospital

Modufolin (6R 5,10-Methylenetetrahydrofolate) and Pemetrexed for Neoadjuvant Rectal Cancer Treatment

Uppsala : Uppsala University Hospital

LifeSeal™ Preliminary Study in Subjects Undergoing Low Anterior Resection

United Kingdom

London and Surrey : Royal Marsden Hospitals NHS Foundation Trust

Bevacizumab And Combination Chemotherapy in Rectal Cancer Until Surgery

Manchester : The Christie NHS Foundation Trust

Dual REctcal Angiogenesis or MEK Inhibition radioTHERAPY Trial